BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 6359378)

  • 1. Possibilities of preventing otitis media by vaccination.
    Mäkelä PH; Karma P; Sipilä M; Pukander J; Leinonen M
    Scand J Infect Dis Suppl; 1983; 39():34-8. PubMed ID: 6359378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal vaccine and otitis media in infancy.
    Mäkelä PH; Karma P; Leinonen MK
    Bull Eur Physiopathol Respir; 1983; 19(2):235-8. PubMed ID: 6871501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.
    van Heerbeek N; Straetemans M; Wiertsema SP; Ingels KJ; Rijkers GT; Schilder AG; Sanders EA; Zielhuis GA
    Pediatrics; 2006 Mar; 117(3):603-8. PubMed ID: 16510637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pneumococcal vaccination on upper respiratory tract infections in children. Design of a follow-up study.
    Rosén C; Christensen P; Hovelius B; Prellner K
    Scand J Infect Dis Suppl; 1983; 39():39-44. PubMed ID: 6359379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R; Givon-Lavi N; Shkolnik L; Yagupsky P; Fraser D
    J Infect Dis; 2000 Apr; 181(4):1322-9. PubMed ID: 10753730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of pneumococcal vaccination in infants and young children].
    Adam D; Scholz H
    Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of otitis media in children by pneumococcal vaccination.
    Karma P; Pukander J; Sipilä M; Timonen M; Pöntynen S; Herva E; Grönroos P; Mäkelä H
    Am J Otolaryngol; 1985; 6(3):173-84. PubMed ID: 3893185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal otitis media vaccine trials.
    Klein JO
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S82-3. PubMed ID: 2648301
    [No Abstract]   [Full Text] [Related]  

  • 12. Otitis media: prospects for prevention.
    Haggard M
    Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A; Metzger DW
    Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against acute otitis media].
    Veenhoven RH; van den Berg YL; Schilder AG; Dhooge IJ; Rijkers GT; Sanders EA
    Ned Tijdschr Geneeskd; 2000 May; 144(20):931-4. PubMed ID: 10827848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
    Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal polysaccharide immunization in infants and children.
    Cowan MJ; Ammann AJ; Wara DW; Howie VM; Schultz L; Doyle N; Kaplan M
    Pediatrics; 1978 Nov; 62(5):721-7. PubMed ID: 31592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.